Skip to main content

Table 3 Results of analysis of PSA-PFS by Cox proportional hazards model

From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

    Univariate    Multivariate  
   Hazard-ratio p 95 % CI Hazard-ratio p 95 % CI
Age ≤75 1      
76≤ 1.213 0.232 0.884- 1.666    
Stage B 1      
C 1.283 0.157 0.908-1.813    
PSA level at diagnosis <20 1    1   
20≤ 2.048 <0.001 1.500-2.797 1.613 0.071 0.959-2.711
Gleason score ≤7 1    1   
8≤ 1.734 0.001 1.256-2.393 1.436 0.064 0.979-2.107
Laterality of cancer detected by biopsy unilateral 1    1   
bilateral 2.102 <0.001 1.533- 2.883 1.523 0.034 1.033-2.245
SVI Negative 1    1   
Positive 1.71 0.032 1.046- 2.793 1.109 0.753 0.582-2.113
  1. PSA-PFS: PSA progression-free survival
  2. 95 % CI: 95 % confidence interval
  3. SVI: seminal vesicle involvement